On January 31, 2024 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, reported that members of its management team will participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference, February 7-8, in New York, NY, Raymond James & Associates’ 45th Annual Institutional Investors Conference, March 4-6, in Orlando, Florida, and Leerink Partners Global Biopharma Conference, March 11-13, in Miami, Florida (Press release, CymaBay Therapeutics, JAN 31, 2024, View Source [SID1234639743]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Date: Wednesday, February 7th, 2024
Time: 1:00pm Eastern Time, Fireside Chat
Webcast: View Source

Raymond James & Associates’ 45th Annual Institutional Investors Conference
Date: Tuesday, March 5th, 2024
Time: 2:50pm Eastern Time, Fireside Chat
Webcast: View Source

Leerink Partners Global Biopharma Conference
Date: Tuesday, March 12th, 2024
Time: 11:20am Eastern Time, Fireside Chat
Webcast: View Source